Target Validation Information
TTD ID	T11309
Target Name	Monocyte chemotactic and activating factor (CCL2)
Type of Target	Clinical trial
Drug Potency against Target	RS-504393	Drug Info	IC50 = 89 nM	[1]
References
REF 1	Privileged structures: a useful concept for the rational design of new lead drug candidates. Mini Rev Med Chem. 2007 Nov;7(11):1108-19.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.